8-K/A

EQUITY 11 4TH TRANCHE AMENDMENT

Company: ABVC BIOPHARMA, INC.
Filed: August 5, 2009
Period of Report: August 5, 2009
Accession Number: 0001173313-09-000069

View Document ↗ View on SEC.gov ↗